Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 1
1993 2
1994 1
1995 1
1996 1
1997 1
1998 1
1999 2
2000 3
2001 3
2002 2
2003 3
2004 4
2005 4
2006 7
2007 6
2008 3
2009 6
2010 4
2011 7
2012 8
2013 5
2014 11
2015 12
2016 10
2017 12
2018 8
2019 17
2020 15
2021 12
2022 8
2023 5
2024 4
2025 12
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

178 results

Results by year

Filters applied: . Clear all
Page 1
Brain metastases.
Shaffrey ME, Mut M, Asher AL, Burri SH, Chahlavi A, Chang SM, Farace E, Fiveash JB, Lang FF, Lopes MB, Markert JM, Schiff D, Siomin V, Tatter SB, Vogelbaum MA. Shaffrey ME, et al. Among authors: markert jm. Curr Probl Surg. 2004 Aug;41(8):665-741. doi: 10.1067/j.cpsurg.2004.06.001. Curr Probl Surg. 2004. PMID: 15354117 Review. No abstract available.
Oncolytic virotherapies for pediatric tumors.
Gross EG, Hamo MA, Estevez-Ordonez D, Laskay NM, Atchley TJ, Johnston JM, Markert JM. Gross EG, et al. Among authors: markert jm. Expert Opin Biol Ther. 2023 Jul-Dec;23(10):987-1003. doi: 10.1080/14712598.2023.2245326. Epub 2023 Oct 5. Expert Opin Biol Ther. 2023. PMID: 37749907 Free PMC article. Review.
IDH status dictates oHSV mediated metabolic reprogramming affecting anti-tumor immunity.
Sahu U, Mullarkey MP, Murphy SA, Anderson JC, Putluri V, Kamal AHM, Park JH, Lee TJ, Ling AL, Kaipparettu BA, Sharma A, Putluri N, Wenzel PL, Willey CD, Chiocca EA, Markert JM, Kaur B. Sahu U, et al. Among authors: markert jm. Nat Commun. 2025 Apr 24;16(1):3874. doi: 10.1038/s41467-025-58911-2. Nat Commun. 2025. PMID: 40274791 Free PMC article.
Herpesviruses as therapeutic agents.
Tufaro F, Markert JM. Tufaro F, et al. Among authors: markert jm. In: Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, Yamanishi K, editors. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Cambridge: Cambridge University Press; 2007. Chapter 76. In: Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, Yamanishi K, editors. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Cambridge: Cambridge University Press; 2007. Chapter 76. PMID: 21348072 Free Books & Documents. Review.
Clinical advances in oncolytic virotherapy for pediatric brain tumors.
Ghajar-Rahimi G, Kang KD, Totsch SK, Gary S, Rocco A, Blitz S, Kachurak K, Chambers MR, Li R, Beierle EA, Bag A, Johnston JM, Markert JM, Bernstock JD, Friedman GK. Ghajar-Rahimi G, et al. Among authors: markert jm. Pharmacol Ther. 2022 Nov;239:108193. doi: 10.1016/j.pharmthera.2022.108193. Epub 2022 Apr 26. Pharmacol Ther. 2022. PMID: 35487285 Free PMC article. Review.
Combination strategies enhance oncolytic virotherapy.
Friedman GK, Markert JM, Gillespie GY. Friedman GK, et al. Among authors: markert jm. Oncotarget. 2017 May 23;8(21):34020-34021. doi: 10.18632/oncotarget.17643. Oncotarget. 2017. PMID: 28487503 Free PMC article. No abstract available.
Oncolytic Virotherapy for the Treatment of Malignant Glioma.
Foreman PM, Friedman GK, Cassady KA, Markert JM. Foreman PM, et al. Among authors: markert jm. Neurotherapeutics. 2017 Apr;14(2):333-344. doi: 10.1007/s13311-017-0516-0. Neurotherapeutics. 2017. PMID: 28265902 Free PMC article. Review.
178 results